Catalyst Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-135
| Closed | -$25K | – | 426 |
|
|
2021
Q2 | $25K | Buy |
135
+5
| +4% | +$926 | ﹤0.01% | 349 |
|
|
2021
Q1 | $20K | Sell |
130
-24
| -16% | -$3.69K | ﹤0.01% | 323 |
|
|
2020
Q4 | $24K | Buy |
+154
| New | +$24K | ﹤0.01% | 306 |
|
|
2018
Q1 | – | Sell |
-13,000
| Closed | -$1.56M | – | 551 |
|
|
2017
Q4 | $1.56M | Buy |
13,000
+8,050
| +163% | +$963K | 0.06% | 142 |
|
|
2017
Q3 | $694K | Buy |
+4,950
| New | +$694K | 0.03% | 187 |
|
|
2016
Q2 | – | Sell |
-5,000
| Closed | -$696K | – | 526 |
|
|
2016
Q1 | $696K | Sell |
5,000
-5,175
| -51% | -$720K | 0.12% | 124 |
|
|
2015
Q4 | $1.94M | Hold |
10,175
| – | – | 0.28% | 88 |
|
|
2015
Q3 | $1.59M | Sell |
10,175
-20,000
| -66% | -$3.13M | 0.21% | 105 |
|
|
2015
Q2 | $5.46M | Buy |
30,175
+30,000
| +17,143% | +$5.42M | 0.64% | 66 |
|
|
2015
Q1 | $30K | Hold |
175
| – | – | ﹤0.01% | 363 |
|
|
2014
Q4 | $32K | Hold |
175
| – | – | ﹤0.01% | 360 |
|
|
2014
Q3 | $29K | Buy |
+175
| New | +$29K | ﹤0.01% | 333 |
|